Symbol
| CLCN7
| contributors: mct - updated : 20-06-2019
|
HGNC name
| chloride channel 7
|
HGNC id
| 2025
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
|  
|
in lysosomal storage disease and neurodegeneration | constitutional
|  
|  
| --over
|  
|
expression of both CLCN7 and OSTM1 is increased in activated microglia, which can account for the increased delivery of CLCN7 to lysosomes | constitutional
|  
|  
|  
| loss of function
|
reduces bone and dentin mineral density but does not affect enamel mineralization | |
Susceptibility
|
to variability of bone mineral density (BMD)in postmenopausal women |
Variant & Polymorphism
other
| significant association of CLCN7 polymorphisms with the variance of BMD and bone resorption marker levels in postmenopausal women |
|
|
Candidate gene
Marker
Therapy target
| | | |
| Clcn7- mice developping severe osteopetrosis | |
mice lacking Clc-7 show altered lysosomal function that leads to severe lysosomal storage |